期刊文献+

平滑肌肉瘤的临床病理研究─—病理组织学、免疫组化及超微结构分析 被引量:2

THE CLINICAL PATHOLOGIC STUDY OF LEIOMYOSARCOMA ANANALYSI5 OF HISTOPATHOLOGY,IMMUNOHISTOCHEMI- STRY AND ULTRASTRUCTURES
下载PDF
导出
摘要 本文报道对26例全身多个部位的平滑肌肉瘤(LMs)附病理组织学、HHF35及Desmin免疫组化及部分病例还进行了超微结构特征研究。结果表明LMS具有较典型的组织学特征:瘤细胞呈杆状,平行排列,胞浆内有肌原纤维。低分化的LMS细胞异型性大,但仍具有上述特征。Desmin标记LMS的阳性率是65%,HHF35的阳性率是96%。两者有显著性差异。其它对照的多种梭形细胞肉瘤中,除恶性纤维组织细胞瘤中可有少数、单个的细胞呈HHF35阳性外,其它均不表达HHF35和Desmin。因此HHF35是标记LMS的敏感性高、特异性强的抗体。透射电镜观察LMS具有特征性的密体和密斑存在。透射电镜观察也是确诊LMS的途径之一。 Twenty six cases of Leiomy osarcomas(LMS)were studid in ourseries.we analysed the histopathology,immunohistochemistry of Desmin and HHF35 ofall cases,features of ultrastructures of 4 cases as well.The prominant histologic featu-res are blunted- ended nucleus arranging in straight parallel lines,and longitudinal myo-fibril presence in cytoplasm. These features can also be identified in poorly differentiatedones.Sixty five percent of LMS expressed Desmin,while ninety six percent of them ex-pressed HHF35.HHF35 is more sensitive one for the detection of LMS,and there is nodifference in sensitivity between well,morderately and poorly differentiated LMS statisti-cally. Apart from there is a few scattered positive cells of HHF35 in Malignant FibrousHistiocytomas,the other spindle cell sarcomas are negative for Desmin and HHF35.SoHHF35 is a good marker for smooth muscle differentiation。There are some specific fea-tures of ultrastructure in LMS,so electron microscopic examination is a good tool forthe diagnosis of LMS.
出处 《癌症》 SCIE CAS CSCD 北大核心 1995年第1期21-23,共3页 Chinese Journal of Cancer
关键词 平滑肌肉瘤 病理组织学 免疫组化 超微结构 Leiomyosarcoma Immunolabeled with HHF35 and Desmin Histopathology Ultrastructure
  • 相关文献

同被引文献20

  • 1许云飞,孔宪国,黄国华.膀胱平滑肌肉瘤研究进展[J].国外医学(泌尿系统分册),2005,25(4):458-461. 被引量:8
  • 2黄勇,李宏伟.膀胱平滑肌肉瘤一例[J].山西医药杂志,2006,35(11):971-971. 被引量:2
  • 3刘波,刘继红,柯昌庶,王少刚,蓝儒竹,王涛,叶章群,马建辉(专家点评).膀胱炎性肌纤维母细胞瘤一例报告并文献复习[J].中华泌尿外科杂志,2007,28(5):335-337. 被引量:15
  • 4Richter ER, Dean RC. I.eiomyosarcoma of the urinary bladderin ateenage male[J]. MilMed,2004,169(2):155-156.
  • 5Tanguay C, Harvey I, Houde M, et al. Leiomyosarcoma of urinary bladder following cyclophosphamide therapy: reporl of two cases[J]. Mod Pathol,2003,16(5) :512-514.
  • 6Venkatraman L, Goepel JR, Steele K, et al. Soft tissue, pelvic, and urinary bladder leiomyosarcoma as second neoplasm fob lowing hereditary retinoblastoma[J]. J Clin Pathol, 2003, S6 (3) :233-236.
  • 7Liang SX, Laksbmanan Y, Woda BA, etal. A high-grade primary leiomyosarcoma of the bladder in a survivor of retinoblastoma[J]. Arch Pathol Lab Med,2001, 125(9):1231-1234.
  • 8Gronau S, Menz CK, Melzner I, et al. lmmunohistomorphologic and molecular cytogenetic analysis of a carcinosareoma of the urinary bladder[J]. Virchows Arch,2002,440(4) :436-440.
  • 9Parekh DJ, Jung C, O'Conner J, et al. Leiomyosarcoma in urinary bladder after cyclophosphamide therapy for retinoblastoma and review of bladder sarcomas[J]. Urology,2002, 60(1) :164.
  • 10Jaidane M, Slama A, Ben Sorba N, et al. Bladder leiomyosareoma: report of a case[J]. Ann Urol (Paris),2000,34 (3) : 179-183.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部